CEB-01 by Cebiotex for Pleomorphic Liposarcoma: Likelihood of Approval

CEB-01 is under clinical development by Cebiotex and currently in Phase I for Pleomorphic Liposarcoma.

Trump calls for 25% tariffs on imports from Canada and Mexico

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Donald Trump plans to use an executive

November 26, 2024

Pharmalittle: We’re reading about the RFK Jr. confirmation hearings, CMS plans for drug-pricing talks, and more

Top of the morning to you, and a fine one it is. Clear blue skies and chilly breezes are wafting across the Pharmalot campus, where

January 30, 2025

Hormonal changes after menopause impact multiple sclerosis severity

A new study by UC San Francisco has found that menopause revs up the progression of multiple sclerosis (MS).

January 10, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.